Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Other Accumulated Expenses (2016 - 2024)

Lifecore Biomedical, Inc. \De\ has reported Other Accumulated Expenses over the past 14 years, most recently at $9.9 million for Q4 2024.

  • Quarterly results put Other Accumulated Expenses at $9.9 million for Q4 2024, up 28.85% from a year ago — trailing twelve months through Nov 2024 was $9.9 million (up 28.85% YoY), and the annual figure for FY2024 was $9.4 million, up 30.97%.
  • Other Accumulated Expenses for Q4 2024 was $9.9 million at Lifecore Biomedical, Inc. \De\, down from $11.4 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for LFCR hit a ceiling of $13.0 million in Q1 2022 and a floor of $3.0 million in Q2 2021.
  • Median Other Accumulated Expenses over the past 5 years was $7.4 million (2023), compared with a mean of $7.7 million.
  • Biggest five-year swings in Other Accumulated Expenses: surged 460.6% in 2020 and later plummeted 69.84% in 2021.
  • Lifecore Biomedical, Inc. \De\'s Other Accumulated Expenses stood at $6.1 million in 2020, then plummeted by 36.55% to $3.9 million in 2021, then surged by 141.37% to $9.4 million in 2022, then dropped by 18.24% to $7.7 million in 2023, then rose by 28.85% to $9.9 million in 2024.
  • The last three reported values for Other Accumulated Expenses were $9.9 million (Q4 2024), $11.4 million (Q3 2024), and $9.4 million (Q2 2024) per Business Quant data.